It is currently undergoing a phase 3 trial (NCT05564169) with 600 participants, employing a randomized, double-blind, placebo-controlled, parallel-group design over 24 weeks, followed by a 24-week extension phase
Both drugs contain semaglutide, a synthetic version of a hormone known as GLP-1, which the body releases into the intestine when people eat food, reducing feelings of hunger
This can often be managedand the odor reducedby dividing the daily prescription into smaller, more frequent doses to improve absorption [2]
B12 is a water-soluble vitamin
Food and Drug Administration said last month that it has received reports of adverse events after people took injections of semaglutide that came from compounding pharmacies
Coverage varies depending on your insurance plan and the services provided